NCT00250575 - A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2009

Conditions

Schizophrenia

Interventions

DRUG

Clozapine

Trial Locations (8)

Novartis Investigational Site, Chiba

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Ishikawa

Novartis Investigative Site, Osaka

Novartis Investigative Site, Saga

Novartis Investigative Site, Tokyo

Novartis Investigative Site, Toyama

Novartis Investigative Site, Yamanashi